SYRE — Spyre Therapeutics, Inc. stock price, charts and financials

QT64Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
104.94
+10.01+10.54%
OverviewShort InterestFilings
SYREQT64Spyre Therapeutics, Inc.·NASDAQ
104.94+10.54%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 2026S-3ASRS-3ASR
Jun 23, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 01, 20268-KCurrent report
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 08, 20264Statement of changes in beneficial ownership
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
#1 / 25 of 427
Page
▼
/ 18